Abstract
The main aim of this study was to compare the response to trivalent inactivated influenza vaccine in children who received a kidney transplant and were on steroid-free versus steroid-based immunosuppression. Groups: 1. Kidney transplant recipients on steroid-free immunosuppression (n = 27); 2. Kidney transplant recipients on steroid-based immunosuppression (n = 39); 3. Healthy controls (n = 21). Hemagglutination inhibition titers against 2007–2008 A/H1N1 and A/H3N2 and B strains were measured before and 8 weeks postvaccination. Postvaccination geometric mean titers to A/H1N1 were significantly lower among both transplant groups than controls (p = 0.025 and 0.015, respectively). Postvaccination titers to H3N2 and B strains were not statistically different between groups. Proportions of participants developing seroprotection were not different among groups. Both kidney transplant groups seroconverted less than controls for A/H1N1 (p = 0.0002) and were no different from controls for B. For A/H3N2, the steroid-free group had the weakest seroconversion (p = 0.008), possibly due to mycophenolate-enhanced exposure and a younger age. Overall, children after kidney transplantation demonstrated a good serologic response to the inactivated influenza vaccine although somewhat lower than controls. Steroid-free immunosuppression did not seem to present an advantage in antibody response. Data on inactivated influenza vaccine safety and efficacy was collected and demonstrated absence of acute rejection or laboratory-proven influenza for 6 months postvaccination.
Similar content being viewed by others
References
Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB (2004) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 53:1–40
Hilleman MR (2002) Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20:3068–3087
HM WEK (1999) Basic Virology. Blackwell Science, Malden, MA
American Academ of Pediatrics, Committee on Infectious Diseases (2004) Recommendations for influenza immunization of children. Pediatrics 113:1441–1447
Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, Wright PF (2002) Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185:147–152
Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR (2000) The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. New Eng J Med 342:225–231
Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. New Eng J Med 342:232–239
Glezen WP (1996) Emerging infections: pandemic influenza. Epidemiol Rev 18:64–76
Vilchez RA, Fung J, Kusne S (2002) The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 4:177–182
Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S (2002) Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2:287–291
No authors listed (2004) Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 4(Suppl 10):160–163
Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC (1998) Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 17:1075–1080
Noble GR, Kaye HS, Yarbrough WB, Fiedler BK, Reed CJ, Felker MB, Kendal AP, Dowdle WR (1977) Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility. J Infect Dis 136(Suppl):S429–S434
Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM (2008) Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine 26:4057–4061
Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR (1997) Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15:1114–1122
Berben L, Denhaerynck K, Schaub S, De Geest S (2009) Prevalence and correlates of influenza vaccination among kidney transplant patients. Prog Transplant 19:312–317
Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE (1995) Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 127:957–960
Furth SL, Neu AM, McColley SA, Case B, Steinhoff M, Fivush B (1995) Immune response to influenza vaccination in children with renal disease. Pediatr Nephrol (Berlin, Germany) 9:566–568
Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ (1996) Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 10:556–560
Mack DR, Chartrand SA, Ruby EI, Antonson DL, Shaw BW Jr, Heffron TG (1996) Influenza vaccination following liver transplantation in children. Liver Transpl Surg 2:431–437
Salles MJ, Sens YA, Boas LS, Machado CM (2009) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 24:E17–E23
Ettenger R, Sarwal MM (2005) Mycophenolate mofetil in pediatric renal transplantation. Transplantation 80:S201–S210
Neuzil KM, Dupont WD, Wright PF, Edwards KM (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20:733–740
Scharpe J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE (2008) Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8:332–337
Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C (2005) Influenza vaccine in healthy children: a meta-analysis. Vaccine 23:2851–2861
Acknowledgements
This study was funded by the National Kidney Foundation of Indiana. The authors are extremely grateful to Dr. Nancy Cox (Director, Influenza Division, WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza Center for Disease Control and Prevention, Atlanta, GA, USA), in whose laboratory the HAI antibody titer assays have been performed, as well as to Dr. Alexander Klimov, Branch Chief, and Dr. Carolyn Bridges, Associate Director of the Division at the same institution, for their support, and to Amanda Balish for technical assistance. In addition, we thank Dr. John Christenson, Professor of Clinical Pediatrics and Director of Infectious Disease Division from J.W. Riley Hospital for Children for his expert advice in pediatric infectious diseases, Dr. Sharon P. Andreoli, Professor of Pediatrics and Director, Section of Pediatric Nephrology and Hypertension from J.W. Riley Hospital for Children for her invaluable input, and at last but not the least, Bethanne Johnston, MSN, CPNP for her diligent work in coordinating the study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. E1
Comparison between tacrolimus and cyclosporine levels and mycophenolate doses between the steroid-free and steroid-based groups (DOC 26 kb)
Rights and permissions
About this article
Cite this article
Nailescu, C., Xu, X., Zhou, H. et al. Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 26, 459–467 (2011). https://doi.org/10.1007/s00467-010-1729-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-010-1729-1